Annual Drug Patent Expirations for NOCDURNA
Nocdurna is a drug marketed by Ferring Pharms Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
Drug patent litigation for NOCDURNA.
This drug has one hundred patent family members in thirty-four countries.
The generic ingredient in NOCDURNA is desmopressin acetate. One supplier is listed for this compound. Additional details are available on the desmopressin acetate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
